DWA
AXGN icon

Dorsey Wright & Associates’s Axogen AXGN Stock Holding History

Dorsey Wright & Associates’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,962
Closed -$19.6K – 293
2022
Q4 		$19.6K Buy
+1,962
New +$21.8K 0.01% 271

Other funds holding AXGN

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dorsey Wright & Associates's AXGN Position: Q1 2023 in Review

Dorsey Wright & Associates sold out of Axogen (AXGN) in Q1 2023, closing a stake of 1,962 shares — an estimated $19.6K sold.

Dorsey Wright & Associates first reported a position in AXGN in Q4 2022 and held it in 1 quarter. The position peaked at $19.6K in Q4 2022. 130 funds tracked by Wall St. Rank hold AXGN as of Q1 2023.

  • Dorsey Wright & Associates reported no remaining Axogen position as of Q1 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,962 Axogen shares in Q1 2023, an estimated $19.6K.
  • Dorsey Wright & Associates first reported a position in Axogen in Q4 2022 and held it in 1 quarter.
  • Dorsey Wright & Associates's Axogen position peaked at $19.6K in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Axogen as of Q1 2023.

Based on Dorsey Wright & Associates's 13F filing for Q1 2023, filed 20 Apr 2023.